Search research articles
Contact Us
Filters
Showing results (281-290 of 471) with videos related to
Page
of 48
Sort By:
European Journal of Heart Failure
|
May 16, 2014
Baseline characteristics and treatment of patients in prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF)
John J V McMurray, Milton Packer, Akshay S Desai, et al.
European Journal of Heart Failure
|
June 11, 2016
Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial
Orly Vardeny, Brian Claggett, Milton Packer, et al.
European Journal of Heart Failure
|
January 28, 2014
The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure: insights from the ASCEND-HF Trial
Mustafa Toma, Justin A Ezekowitz, Jeffrey A Bakal, et al.
European Journal of Heart Failure
|
August 25, 2007
Effect of carvedilol and metoprolol on the mode of death in patients with heart failure
Willem J Remme, John G Cleland, Leif Erhardt, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
October 6, 2021
Growth differentiation factor 15 predicts poor prognosis in patients with heart failure and reduced ejection fraction and anemia: results from RED-HF
Thor Ueland, Lars Gullestad, Lei Kou, et al.
European Heart Journal
|
October 26, 2012
Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies
Stuart J Pocock, Cono A Ariti, John J V McMurray, et al.
Cardiovascular Drugs and Therapy
|
May 27, 2004
A description of the clinical characteristics at baseline of patients recruited into the Carvedilol or Metoprolol European Trial (COMET)
John G F Cleland, Kevin Goode, Leif Erhardt, et al.
Journal of the American College of Cardiology
|
May 13, 2024
Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Impaired Renal Function
Shingo Matsumoto, Alasdair D Henderson, Li Shen, et al.
Journal of the American College of Cardiology
|
March 9, 2019
B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial
Peder Langeland Myhre, Muthiah Vaduganathan, Brian Claggett, et al.
European Journal of Heart Failure
|
October 13, 2012
Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial
Satyam Sarma, Robert J Mentz, Mary J Kwasny, et al.
Page
of 48
Search research articles
Search
Showing results (281-290 of 471) with videos related to
Sort By:
Page
of 48
European Journal of Heart Failure
|
May 16, 2014
Baseline characteristics and treatment of patients in prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF)
John J V McMurray, Milton Packer, Akshay S Desai, et al.
European Journal of Heart Failure
|
June 11, 2016
Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial
Orly Vardeny, Brian Claggett, Milton Packer, et al.
European Journal of Heart Failure
|
January 28, 2014
The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure: insights from the ASCEND-HF Trial
Mustafa Toma, Justin A Ezekowitz, Jeffrey A Bakal, et al.
European Journal of Heart Failure
|
August 25, 2007
Effect of carvedilol and metoprolol on the mode of death in patients with heart failure
Willem J Remme, John G Cleland, Leif Erhardt, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
October 6, 2021
Growth differentiation factor 15 predicts poor prognosis in patients with heart failure and reduced ejection fraction and anemia: results from RED-HF
Thor Ueland, Lars Gullestad, Lei Kou, et al.
European Heart Journal
|
October 26, 2012
Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies
Stuart J Pocock, Cono A Ariti, John J V McMurray, et al.
Cardiovascular Drugs and Therapy
|
May 27, 2004
A description of the clinical characteristics at baseline of patients recruited into the Carvedilol or Metoprolol European Trial (COMET)
John G F Cleland, Kevin Goode, Leif Erhardt, et al.
Journal of the American College of Cardiology
|
May 13, 2024
Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Impaired Renal Function
Shingo Matsumoto, Alasdair D Henderson, Li Shen, et al.
Journal of the American College of Cardiology
|
March 9, 2019
B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial
Peder Langeland Myhre, Muthiah Vaduganathan, Brian Claggett, et al.
European Journal of Heart Failure
|
October 13, 2012
Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial
Satyam Sarma, Robert J Mentz, Mary J Kwasny, et al.
Page
of 48